Provided by Tiger Trade Technology Pte. Ltd.

Conmed

52.15
+1.082.11%
Volume:133.73K
Turnover:6.95M
Market Cap:1.56B
PE:28.33
High:52.49
Open:50.90
Low:50.90
Close:51.07
52wk High:56.64
52wk Low:31.44
Shares:29.95M
Float Shares:29.86M
Volume Ratio:0.84
T/O Rate:0.45%
Dividend:0.20
Dividend Rate:0.38%
EPS(TTM):1.84
EPS(LYR):1.52
ROE:5.53%
ROA:4.14%
PB:1.50
PE(LYR):34.40

Loading ...

BRIEF-Conmed Q1 Adjusted EPS USD 0.89 Vs. IBES Estimate USD 0.82

Reuters
·
Apr 30

Conmed Q1 Net Income USD 13.828 Million

THOMSON REUTERS
·
Apr 30

Conmed Q1 Income From Operations USD 25.415 Million

THOMSON REUTERS
·
Apr 30

Conmed Q1 Pretax Profit USD 18.355 Million

THOMSON REUTERS
·
Apr 30

Earning Preview: Conmed Q1 revenue expected to decrease by 0.92%, and institutional views are cautious

Earnings Agent
·
Apr 23

A Look At CONMED’s (CNMD) Valuation After Mixed Q4 Beat And Full Year Guidance Miss

Simply Wall St.
·
Apr 11

CONMED Up Nearly 6%, On Track for Largest Percent Increase Since May 2025 -- Data Talk

Dow Jones
·
Apr 09

CONMED publishes 2025 annual report, posts net sales of USD 1.4 billion

Reuters
·
Apr 08

CONMED announces annual shareholder meeting via webcast

Reuters
·
Apr 07

Press Release: CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

Dow Jones
·
Apr 03

CONMED to report first-quarter results, host conference call after market close

Reuters
·
Apr 03

BRIEF-Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED

Reuters
·
Mar 18

Micro-Tech Endoscopy Signs Definitive Agreement to Acquire Duraclip™, Precisor®, and Optibite® Product Lines From Conmed

THOMSON REUTERS
·
Mar 18

Conmed assumed with an Equal Weight at Wells Fargo

TIPRANKS
·
Mar 18

BUZZ-Piper Sandler downgrades CONMED rating to 'neutral' on lack of catalysts

Reuters
·
Mar 17

Piper Sandler Downgrades CONMED to Neutral From Overweight, Adjusts PT to $39 From $55

MT Newswires Live
·
Mar 17

Conmed Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
Mar 17

Conmed downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
Mar 17

Conmed Corp : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $39 From $55

THOMSON REUTERS
·
Mar 17

U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson

Reuters
·
Mar 17